digg/ai
1d ago

Pharma Drugs Outpace AI Labs in Projected 2026 Run Rates

——0——
Original post
bilal#1483@BILALTWOVEC@DRSAMUELBHUME
DrSamuelBHume
Samuel Hume@DRSAMUELBHUME

How the 2026 run rates of the top AI labs and pharmaceuticals compare 1. Tirzepatide (~$51 B) 2. Anthropic (~$45 B) 3. Semaglutide (~$33 B) 4. Pembrolizumab (~$32 B) 5. Apixaban (~$25 B) 6. OpenAI (~$25 B) 7. Dupilumab (~$20 B) 8. Risankizumab (~$18 B) 9. Daratumumab (~$16 B) 10. Biktarvy (~$14 B) Tech people, come to bio: there are lots of diseases left to solve

12:46 PM · May 14, 2026 View on X
Reposted by
bilal#1483@BILALTWOVEC
QUOTE POSTPranav Shyam#1363Pranav Shyam@RECURSEPARADOX

Tech people should sure come to bio not for money but for glory

Samuel HumeSamuel Hume@DrSamuelBHume

How the 2026 run rates of the top AI labs and pharmaceuticals compare 1. Tirzepatide (~$51 B) 2. Anthropic (~$45 B) 3. Semaglutide (~$33 B) 4. Pembrolizumab (~$32 B) 5. Apixaban (~$25 B) 6. OpenAI (~$25 B) 7. Dupilumab (~$20 B) 8. Risankizumab (~$18 B) 9. Daratumumab (~$16 B) 10. Biktarvy (~$14 B) Tech people, come to bio: there are lots of diseases left to solve

7:46 PM · May 14, 2026 · 90.7K Views
9:58 PM · May 15, 2026 · 910 Views
Pharma Drugs Outpace AI Labs in Projected 2026 Run Rates · Digg